Through the use of gene editing technology to make hepatocytes express LOX-1 ectopically, the liver can continuously clear the Ox-LDL accumulated in the circulation of advanced atherosclerosis, and finally inhibit the fast development of advanced atherosclerosis and occurrence of plaque rupture. This evidence concerns the gene OLR1 and atherosclerosis.